Login / Signup

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab.

Katariina M HuttererAlla PolozovaScott KuhnsHelen J McBrideXingxiang CaoJennifer Liu
Published in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2019)
Based on the comprehensive analytical similarity assessment, ABP 980 is analytically highly similar to the reference product, trastuzumab.
Keyphrases
  • epidermal growth factor receptor
  • metastatic breast cancer
  • liquid chromatography
  • tyrosine kinase
  • mass spectrometry